Assessment of High Risk Pregnancy Flashcards
1
Q
Assessment of Risk Factors
types
A
-
Biophysical Risks
> factors tht originate w/in mother or fetus & affect development or functioning of either one or both -
Psychosocial Risks
> maternal behaviors & adverse lifestyle -
Sociodemographic Risks
> arise from mother & her family - Environmental Risks
2
Q
Antepartum Testing/Biophysical Assessment
goals
A
-
2 Goals:
> identify fetuses at risk for injury caused by acute or chronic interruption of oxygen so permanent injury or death might be prevented
> identify appropriate oxygenated fetuses so unnecessary intervention can be avoided
3
Q
Ultrasonography
biophysical assess
indications
A
-
Indications for use
> fetal heart rate activity
> gestational age
> fetal growth
> fetal anatomy
> fetal genetic disorders
> placental position & func
> adjunct to other invasive tests
4
Q
Ultrasonography
well-being
nurse role
A
-
Fetal Well-Being
> doppler blood flow analysis
> amniotic fluid volume
> biophysical profile (BPP) -
Nursing Role
> counseling & education regarding the procedure
5
Q
Amniocentesis
biochemical
A
-
Indication for Use
> genetic concerns; women >35yrs, family hx of chromosomal abns
> fetal maturity; L/S & S/A ratios
> fetal hemolytic disease - Maternal complications
- Fetal complications
6
Q
Chorionic Villus Sampling (CVS)
biochemical
A
- Earlier diagnosis & rapid results
- Performed btwn 10-13wks of gestation
- Removal of small tissue specimen from fetal portion of placenta
> chorionic villi originate in zygote > tissue reflects genetic makeup of fetus
7
Q
Alpha-Fetoprotein (AFP)
biochemical - maternal assays
A
- Maternal serum lvls screened for neural tube defects (NTDs)
- 80-85% of open NTDs & abd wall defects can be detected early
- Recommended for all pregnant women
8
Q
Mutliple Marker Screens
biochemical - maternal assays
A
- Detects chromosomal abnormalities
- PAPP-A, B-hCG, hCG markers associated w/ incrd risk for trisomy 21 (Down’s)
9
Q
Coombs’ Test
biochemical - maternal assay
A
- Rh incompatibility
- Detects other antibodies for incompatibility w/ maternal antigens
10
Q
Cell Free DNA in Maternal Blood
biochemical - maternal assay
A
- A new screening message for noninvasive prenatal genetic diagnosis
> fetal Rh status
> fetal gender
> paternally transmitted single gene disorders - Works by amplifying cell free DNA
11
Q
Antepartal Assessment Using Electronic Fetal Monitoring
A
-
Goal
> to determine if the intrauterine envir’t is supportive to fetus -
Nonstress test (fetal activity determination)
> procedure
> interpretation - Vibroacoustic stimulation
12
Q
Contraction Stress Test (CST)
antepartal assessment using electronic fetal monitoring
A
- Procedure
> stimulate the stress the fetus experiences in the 1st stage of labor
> nipple-stimulated contraction test
> oxytocin-stimulated contraction test - Interpretation
- Provides a warning of fetal compromise earlier than NST